ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Tricuspid valve disease

August 17, 2022
This article is a practical review of a standalone resource on atrioventricular valve regurgitation that has not received much attention in contemporary practice but has much potential to change the understanding and practice of cardiothoracic surgeons who deal with this major disease subset burden in their careers.
August 8, 2022
Tricuspid valve repair with patch augmentation is used to overcome the valve regurgitation caused by malcoaptation of leaflets. This video shows the technique used when the anterior leaflet is too thin to hold the suture line safely; the possibility of tearing the leaflet after cutting and suturing exists. The augmentation was made at the annular level with no contact on the leaflet itself. This technique ensures a much more secure repair, as the suturing is only on the fibromuscular tissue. An artificial chordal support to the flail leaflet technique is also demonstrated.
July 14, 2022
Pericardial constriction from expanded polytetrafluoroethylene (ePTFE) pericardial replacement membrane is rare. The condition should be considered in the differential diagnosis when a patient with a history of prior cardiac surgery presents with symptoms and signs of heart failure.
December 7, 2021
This is an original, narrated video demonstrating reconstruction of the aorto-mitral curtain with multiple bovine pericardial patches in a case of invasive aortic root endocarditis.
November 19, 2021
Impressive  decrease of death (by approximaltely 40% !) in 2 years from a small RCT in elective structural heart surgery for degeneration. The assumption is  a benefit  by improvement in right ventricular dynamics
October 26, 2021
Severe leaflet tethering which is mainly the result of long standing Tricuspid valve regurgitation and RV dilatation is the main predictor of residual and/or recurrent valve insufficiency. We present the Novel technique of Papillary Muscle Cross Control which effectively overcomes the leaflet tethering in a very practical, simple , and reproducible manner by controlled approximation of the anterior papillary muscle to the posterior/septal part of the semi-rigid annuloplasty ring. The papillary cross-control technique is applicable both as a supplementary technique after ring annuloplasty for functional TR with tethered cusps and also for completing the repair in more complex cases of organic valve disease such as Ebstein Anomaly. Our early and late results with this technique has been quite encouraging.
October 1, 2021
A scholarly narrative on the utility of quantifying the performance of the right ventricle: the RV has been hitherto empirically assessed in many clinical setups.
June 4, 2021
On May 25, 2021, Dr. David Heimansohn successfully performed the first surgical implantation of biopolymer Tria™ heart valve in a patient with mitral valve disease at Ascension St. Vincent Hospital, Indianapolis, IN. 
March 25, 2021
Holmgren et al. report the long-term outcome of aortic valve replacement patients for bicuspid or tricuspid aortic valve pathologies within a Swedish cohort. In their analysis, patients with bicuspid valve morphology showed an independent association with improved outcome, even matching the general population´s prognosis.
March 23, 2021
In this video, the authors demonstrate the step-by-step approach to perform septal leaflet augmentation and several neochordae that allowed effective correction of severe tricuspid regurgitation with annular dilation and complex tethering of valve leaflets.

Pages